Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1999 Nov;58(Suppl 1):I99–I102. doi: 10.1136/ard.58.2008.i99

Interleukin 10 treatment for rheumatoid arthritis

C St
PMCID: PMC1766579  PMID: 10577984

Full Text

The Full Text of this article is available as a PDF (63.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aman M. J., Tretter T., Eisenbeis I., Bug G., Decker T., Aulitzky W. E., Tilg H., Huber C., Peschel C. Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood. 1996 Jun 1;87(11):4731–4736. [PubMed] [Google Scholar]
  2. Aste-Amezaga M., Ma X., Sartori A., Trinchieri G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol. 1998 Jun 15;160(12):5936–5944. [PubMed] [Google Scholar]
  3. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 1991 Dec 1;174(6):1549–1555. doi: 10.1084/jem.174.6.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bonder C. S., Finlay-Jones J. J., Hart P. H. Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain. Immunology. 1999 Apr;96(4):529–536. doi: 10.1046/j.1365-2567.1999.00711.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cenci E., Romani L., Mencacci A., Spaccapelo R., Schiaffella E., Puccetti P., Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol. 1993 May;23(5):1034–1038. doi: 10.1002/eji.1830230508. [DOI] [PubMed] [Google Scholar]
  6. Chernoff A. E., Granowitz E. V., Shapiro L., Vannier E., Lonnemann G., Angel J. B., Kennedy J. S., Rabson A. R., Wolff S. M., Dinarello C. A. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol. 1995 May 15;154(10):5492–5499. [PubMed] [Google Scholar]
  7. Chomarat P., Banchereau J., Miossec P. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum. 1995 Aug;38(8):1046–1054. doi: 10.1002/art.1780380805. [DOI] [PubMed] [Google Scholar]
  8. Chomarat P., Rissoan M. C., Banchereau J., Miossec P. Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med. 1993 Feb 1;177(2):523–527. doi: 10.1084/jem.177.2.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cohen S. B., Katsikis P. D., Chu C. Q., Thomssen H., Webb L. M., Maini R. N., Londei M., Feldmann M. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum. 1995 Jul;38(7):946–952. doi: 10.1002/art.1780380710. [DOI] [PubMed] [Google Scholar]
  10. Cush J. J., Splawski J. B., Thomas R., McFarlin J. E., Schulze-Koops H., Davis L. S., Fujita K., Lipsky P. E. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 1995 Jan;38(1):96–104. doi: 10.1002/art.1780380115. [DOI] [PubMed] [Google Scholar]
  11. Dugas N., Vouldoukis I., Bécherel P., Arock M., Debré P., Tardieu M., Mossalayi D. M., Delfraissy J. F., Kolb J. P., Dugas B. Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin-10 production by human macrophages. Eur J Immunol. 1996 Jun;26(6):1394–1398. doi: 10.1002/eji.1830260632. [DOI] [PubMed] [Google Scholar]
  12. Elenkov I. J., Webster E., Papanicolaou D. A., Fleisher T. A., Chrousos G. P., Wilder R. L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol. 1998 Sep 1;161(5):2586–2593. [PubMed] [Google Scholar]
  13. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991 May 15;146(10):3444–3451. [PubMed] [Google Scholar]
  14. Groux H., Cottrez F., Rouleau M., Mauze S., Antonenko S., Hurst S., McNeil T., Bigler M., Roncarolo M. G., Coffman R. L. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol. 1999 Feb 1;162(3):1723–1729. [PubMed] [Google Scholar]
  15. Hagenbaugh A., Sharma S., Dubinett S. M., Wei S. H., Aranda R., Cheroutre H., Fowell D. J., Binder S., Tsao B., Locksley R. M. Altered immune responses in interleukin 10 transgenic mice. J Exp Med. 1997 Jun 16;185(12):2101–2110. doi: 10.1084/jem.185.12.2101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hart P. H., Hunt E. K., Bonder C. S., Watson C. J., Finlay-Jones J. J. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol. 1996 Oct 15;157(8):3672–3680. [PubMed] [Google Scholar]
  17. Horton M. R., Burdick M. D., Strieter R. M., Bao C., Noble P. W. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J Immunol. 1998 Mar 15;160(6):3023–3030. [PubMed] [Google Scholar]
  18. Isomaki P., Luukkainen R., Saario R., Toivanen P., Punnonen J. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum. 1996 Mar;39(3):386–395. doi: 10.1002/art.1780390306. [DOI] [PubMed] [Google Scholar]
  19. Jeannin P., Lecoanet S., Delneste Y., Gauchat J. F., Bonnefoy J. Y. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 1998 Apr 1;160(7):3555–3561. [PubMed] [Google Scholar]
  20. Jenkins J. K., Malyak M., Arend W. P. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res. 1994 Feb;13(1):47–54. [PubMed] [Google Scholar]
  21. Joosten L. A., Lubberts E., Durez P., Helsen M. M., Jacobs M. J., Goldman M., van den Berg W. B. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 1997 Feb;40(2):249–260. doi: 10.1002/art.1780400209. [DOI] [PubMed] [Google Scholar]
  22. Joyce D. A., Gibbons D. P., Green P., Steer J. H., Feldmann M., Brennan F. M. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol. 1994 Nov;24(11):2699–2705. doi: 10.1002/eji.1830241119. [DOI] [PubMed] [Google Scholar]
  23. Kasama T., Strieter R. M., Lukacs N. W., Lincoln P. M., Burdick M. D., Kunkel S. L. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest. 1995 Jun;95(6):2868–2876. doi: 10.1172/JCI117993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kasama T., Yamazaki J., Hanaoka R., Miwa Y., Hatano Y., Kobayashi K., Negishi M., Ide H., Adachi M. Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: possible involvement of endogenous interleukin-10 and tumor necrosis factor alpha. Arthritis Rheum. 1999 Jan;42(1):100–109. doi: 10.1002/1529-0131(199901)42:1<100::AID-ANR13>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  25. Katsikis P. D., Chu C. Q., Brennan F. M., Maini R. N., Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med. 1994 May 1;179(5):1517–1527. doi: 10.1084/jem.179.5.1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Katsikis P. D., Cohen S. B., Londei M., Feldmann M. Are CD4+ Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function. Int Immunol. 1995 Aug;7(8):1287–1294. doi: 10.1093/intimm/7.8.1287. [DOI] [PubMed] [Google Scholar]
  27. Kawakami A., Eguchi K., Matsuoka N., Tsuboi M., Urayama S., Kawabe Y., Aoyagi T., Maeda K., Nagataki S. Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis. Immunology. 1997 Jun;91(2):252–259. doi: 10.1046/j.1365-2567.1997.00244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kelly J. P., Bancroft G. J. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J Immunol. 1996 Feb;26(2):356–364. doi: 10.1002/eji.1830260214. [DOI] [PubMed] [Google Scholar]
  29. Kennedy M. K., Torrance D. S., Picha K. S., Mohler K. M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol. 1992 Oct 1;149(7):2496–2505. [PubMed] [Google Scholar]
  30. Lee M. S., Wogensen L., Shizuru J., Oldstone M. B., Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest. 1994 Mar;93(3):1332–1338. doi: 10.1172/JCI117092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Levy Y., Brouet J. C. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest. 1994 Jan;93(1):424–428. doi: 10.1172/JCI116977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes J., Fourrier B. M., Galanaud P., Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 1994 Nov;37(11):1647–1655. doi: 10.1002/art.1780371114. [DOI] [PubMed] [Google Scholar]
  33. MacNeil I. A., Suda T., Moore K. W., Mosmann T. R., Zlotnik A. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol. 1990 Dec 15;145(12):4167–4173. [PubMed] [Google Scholar]
  34. Maeda H., Kuwahara H., Ichimura Y., Ohtsuki M., Kurakata S., Shiraishi A. TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol. 1995 Nov 15;155(10):4926–4932. [PubMed] [Google Scholar]
  35. Mertz P. M., DeWitt D. L., Stetler-Stevenson W. G., Wahl L. M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem. 1994 Aug 19;269(33):21322–21329. [PubMed] [Google Scholar]
  36. Miossec P., van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 1997 Dec;40(12):2105–2115. doi: 10.1002/art.1780401203. [DOI] [PubMed] [Google Scholar]
  37. Morita Y., Yamamura M., Kawashima M., Harada S., Tsuji K., Shibuya K., Maruyama K., Makino H. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum. 1998 Sep;41(9):1669–1676. doi: 10.1002/1529-0131(199809)41:9<1669::AID-ART19>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  38. Murray P. J., Wang L., Onufryk C., Tepper R. I., Young R. A. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol. 1997 Jan 1;158(1):315–321. [PubMed] [Google Scholar]
  39. Parry S. L., Sebbag M., Feldmann M., Brennan F. M. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha. J Immunol. 1997 Apr 15;158(8):3673–3681. [PubMed] [Google Scholar]
  40. Pennline K. J., Roque-Gaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol. 1994 May;71(2):169–175. doi: 10.1006/clin.1994.1068. [DOI] [PubMed] [Google Scholar]
  41. Porrini A. M., Gambi D., Reder A. T. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J Neuroimmunol. 1995 Aug;61(1):27–34. doi: 10.1016/0165-5728(95)00070-i. [DOI] [PubMed] [Google Scholar]
  42. Powrie F., Menon S., Coffman R. L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol. 1993 Sep;23(9):2223–2229. doi: 10.1002/eji.1830230926. [DOI] [PubMed] [Google Scholar]
  43. Reparon-Schuijt C. C., van Esch W. J., van Kooten C., Levarht E. W., Breedveld F. C., Verweij C. L. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients. Arthritis Rheum. 1998 Dec;41(12):2211–2220. doi: 10.1002/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  44. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol. 1994 Jun;24(6):1434–1440. doi: 10.1002/eji.1830240629. [DOI] [PubMed] [Google Scholar]
  45. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890–1893. doi: 10.1073/pnas.89.5.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sherry B., Espinoza M., Manogue K. R., Cerami A. Induction of the chemokine beta peptides, MIP-1 alpha and MIP-1 beta, by lipopolysaccharide is differentially regulated by immunomodulatory cytokines gamma-IFN, IL-10, IL-4, and TGF-beta. Mol Med. 1998 Oct;4(10):648–657. [PMC free article] [PubMed] [Google Scholar]
  47. Sutterwala F. S., Noel G. J., Salgame P., Mosser D. M. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med. 1998 Jul 6;188(1):217–222. doi: 10.1084/jem.188.1.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Thompson-Snipes L., Dhar V., Bond M. W., Mosmann T. R., Moore K. W., Rennick D. M. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med. 1991 Feb 1;173(2):507–510. doi: 10.1084/jem.173.2.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tonnetti L., Spaccapelo R., Cenci E., Mencacci A., Puccetti P., Coffman R. L., Bistoni F., Romani L. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol. 1995 Jun;25(6):1559–1565. doi: 10.1002/eji.1830250614. [DOI] [PubMed] [Google Scholar]
  50. Walmsley M., Katsikis P. D., Abney E., Parry S., Williams R. O., Maini R. N., Feldmann M. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 1996 Mar;39(3):495–503. doi: 10.1002/art.1780390318. [DOI] [PubMed] [Google Scholar]
  51. Wanidworanun C., Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol. 1993 Dec 15;151(12):6853–6861. [PubMed] [Google Scholar]
  52. Willems F., Marchant A., Delville J. P., Gérard C., Delvaux A., Velu T., de Boer M., Goldman M. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol. 1994 Apr;24(4):1007–1009. doi: 10.1002/eji.1830240435. [DOI] [PubMed] [Google Scholar]
  53. Wogensen L., Lee M. S., Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp Med. 1994 Apr 1;179(4):1379–1384. doi: 10.1084/jem.179.4.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 Nov 1;174(5):1209–1220. doi: 10.1084/jem.174.5.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. van Roon J. A., van Roy J. L., Gmelig-Meyling F. H., Lafeber F. P., Bijlsma J. W. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum. 1996 May;39(5):829–835. doi: 10.1002/art.1780390516. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES